By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 21 January 2025 SciLifeLab Lund, which Lp3 is part of, arranges interesting seminars with presentations of its different units and local core facilities together with user presentations. So please take the opportunity to learn more of our different services which could be useful in you research. The SciLifeL

https://www.lp3.lu.se/article/welcome-scilifelab-seminars - 2025-07-07

By cob-ars [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 23 January 2025 LP3 was presented at the yearly meeting for MAX IV synchrotron users held in January 2025. Dr. Celeste Sele presented two posters about LP3's capabilities within protein crystallisation/biophysics and structure determination as well as protein production within the national research infrastructure Protein

https://www.lp3.lu.se/article/lp3-36th-max-iv-user-meeting - 2025-07-07

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 17 February 2025 You don't want to miss this! PPS is hosting, and more info on registration will come later! Please follow our PPS linkedin for releases of the preliminary program and registration details-coming soon.Alternatively, see www.pps.gu.se/en or www.p4eu.orgFor urgent enquiries please contact e-mai

https://www.lp3.lu.se/article/heads-next-p4eu-meeting-will-be-gothenburg-25th-27th-august-2025 - 2025-07-07

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 10 March 2025 In the very last number of LUM, there was a popular science presentation of LP3 and our work. "LP3 has since the start in 2012, produced proteins for around 300 research projects - from drug development to sustainable chemical processes"Read the full article (in Swedish) here on the Lund Univer

https://www.lp3.lu.se/article/article-about-lp3-lund-university-magazine - 2025-07-07

By Heather [dot] Sullivan [at] Biol [dot] lu [dot] se (Heather Sullivan) - published 28 March 2025 LP3 will provide capabilities within protein production, biophysical characterization and protein structure determination to help VIGILANT achieve its goals. VIGILANT: Targeting ER Import And Activation Of Viral Glycoproteins: Towards Broad-Spectrum AntiviralsLP3 will provide capabilities within prot

https://www.lp3.lu.se/article/lp3-collaborates-new-eu-research-project-vigilant - 2025-07-07

By Heather [dot] Sullivan [at] Biol [dot] lu [dot] se (Heather Sullivan) - published 4 April 2025 Registration is now open for the 21st Protein Production and Purification Partnership in Europe Meeting. REGISTRATION is now OPEN for the 21st P4EU Meeting in Gothenburg, 25th-27th August 2025! Hosted this year by the Universities of Lund and Gothenburg of Protein Production Sweden.Information regardi

https://www.lp3.lu.se/article/registration-now-open-21st-p4eu-meeting-gothenburg-aug-25-27th - 2025-07-07

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 23 June 2025 LP3 attended the 28th Swedish Conference on Macromolecular Structure & Function (SWEPROT) in Tällberg last weekend and presented our capabilities through several posters. Several PPS team members visited the meeting with around 130 other participants from the Swedish protein science community.Mo

https://www.lp3.lu.se/article/lp3-tallberg-conference-2025 - 2025-07-07

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 25 June 2025 Several LP3 members presented our capabilities with a poster at the first conference held in Linxs new facilities. The conference was held to celebrate the opening of the LINXS at Brunnshög in the newly build Loop (more info here on Linxs homepage). Several staff members of PPS visited the openi

https://www.lp3.lu.se/article/lp3-inagural-conference-new-linxs - 2025-07-07

Published 18 July 2020 3D structure of Nsp10 from the new corona virus SARS-cov-2. An international collaboration between the Lund Protein Production Platform (LP3), the UCL School of Pharmacy and ESS, through its DEMAX platform, has initiated biophysical and structural studies of three non-structural proteins from the novel coronavirus, SARS CoV-2, the causative agent of COVID-19. Recently we man

https://www.lp3.lu.se/article/collaborative-research-project-corona-virus-proteins - 2025-07-07

Published 8 October 2020 Results from the collaborative corona virus protein research project involvning Lund Protein Production Platform (LP3), the UCL School of Pharmacy and ESS, through its DEMAX platform have been published in the International Journal of Molecular Sciences.

https://www.lp3.lu.se/article/results-collaborative-corona-virus-protein-research-project-published - 2025-07-07

Published 1 July 2019 LP3 activities will be limited during the summer, especially in July and early August. In the meantime, here’s some recommended summer reading:

https://www.lp3.lu.se/article/recommended-summer-reading - 2025-07-07

Published 29 March 2019 FragMAX, a project run in collaboration between LP3, MAXIV, Astra Zeneca and SARomics Biostructures, has been awarded funding from the Swedish Research Council. The project aims to establish a fragment based screening facility, enabling scientists and small companies to screen low molecular weight fragments for binding to target proteins using X-ray crystallography.Read mor

https://www.lp3.lu.se/article/fragmax-awarded-funding-swedish-research-council - 2025-07-07

Published 31 December 2018 LP3 was successful in its application for renewal of beamtime access at BioMAX (the X-ray macromolecular crystallography beamline of MAX IV). The protein structure pipeline at LP3 is now established. Users can get their protein samples crystallised and the resulting crystals can on a regular basis be evaluated for diffraction and data can be collected. Processing of X-ra

https://www.lp3.lu.se/article/renewal-beamtime-access-biomax-and-allocated-time-scilifelab-cryo-em-facility - 2025-07-07

Published 30 December 2018 A team from the Lund Protein Production Platform, Karolinska Institute, and the European Spallation Source have published an optimized approach to high-yield protein deuteration at low cost, for neutron protein crystallography in Archives of Biochemistry and Biophysics (external website). 

https://www.lp3.lu.se/article/more-less-low-cost-high-yield-protein-deuteration-neutron-crystallography - 2025-07-07

Published 29 December 2018 The baculovirus-insect cell expression system has become one of the most widely used eukaryotic expression systems for heterologous protein production in many laboratories. To date, limited data has been presented in the literature to benchmark the protocols used for baculovirus vectors, and this study facilitates the selection of a system for optimal production of targe

https://www.lp3.lu.se/article/baculovirus-driven-protein-expression-insect-cells-benchmarking-study - 2025-07-07

Published 28 December 2018 LP3 has been granted beamtime at the X-ray macromolecular crystallography beamline of MAX IV, BioMAX. This allows users to have their crystals rapidly evaluated for diffraction. With funding from BioCARE (a governmental supported strategic research area in cancer (external website)) the Lund Protein Production Platform, LP3, can also offer the possibility to process data

https://www.lp3.lu.se/article/beamtime-biomax - 2025-07-07

Published 30 December 2017 The Lund Protein Production Platform is one of several protein production facilities in Sweden that form the Protein Production Network Sweden (PPNS), each with its own specialties and focus. PPNS is an informal network formed in 2013 between protein production facilities at Swedish universities. The overall aim is to make competence and protein production methodologies

https://www.lp3.lu.se/article/protein-production-network-sweden-launches-new-website - 2025-07-07

Published 29 December 2017 The DEuteration and MAcromolecular Xtallization (DEMAX) platform of the European Spallation Source ERIC (ESS) moved into Biology House A at Lund University and is now co-localized with the Lund Protein Production Platform (LP3). DEMAX (external website) and LP3 are collaborating to coordinate their efforts to develop cost-effective production of deuterated biomaterials (

https://www.lp3.lu.se/article/partnership-between-lp3-and-demax - 2025-07-07

Published 30 December 2016 A Bioscreen C system for microbiological growth studies is now available at LP3. The Bioscreen C (external website) can incubate, shake, and measure the turbidity (OD) of up to 200 samples simultaneously. 

https://www.lp3.lu.se/article/new-system-microbiological-growth-monitoring - 2025-07-07

Published 30 December 2014 LP3 is part of the Protein Production Network Sweden (PPNS) that aims to make multiple protein expression hosts, methodologies and competence in protein production available to the Swedish academic life science community. Collaboration between Swedish protein production sites is crucial in order to solve complex scientific questions and in a pilot effort to test a new jo

https://www.lp3.lu.se/article/protein-production-network-sweden-pilot-expression-screen-completed - 2025-07-07